Catalyst Wire Dossier Catalyst Wire Dossier

Linagliptin + Metformin (low-dose combination)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Linagliptin + Metformin (low-dose combination), covering 2019-10-25 to 2019-10-25. Get the full timeline:

Most recent: Clinical Trial Update: Effect of Low Dose Combination of Linagliptin + Metformin to Prevent Diabetes [Phase 3]

See pricing